Pulmonary delivery of inhalable nanoparticles: dry powder inhalers-Reference-Cited by-同舟云学术

Pulmonary delivery of inhalable nanoparticles: dry powder inhalers

Published:2011-10 Issue:10 Volume:2 Page:1313-1324
ISSN:2041-5990
Container-title:Therapeutic Delivery
language:en
Short-container-title:Therapeutic Delivery

Author:

Al-Hallak MHD Kamal¹²,Sarfraz Muhammad Khan¹³,Azarmi Shirzad¹⁴,Roa Wilson H⁵,Finlay Warren H⁶,Löbenberg Raimar

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2N8, Canada

2. Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic

3. Faculty of Pharmacy and Alternative Medicine, The Islamia University of Bahawalpur, Bahawalpur, Pakistan

4. Research Center for Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

5. Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada

6. Department of Mechanical Engineering, University of Alberta, Edmonton, AB, T6G 2G8, Canada

Abstract

Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility. Moreover, the article summarizes up-to-date in vivo applications of inhalable NPs as dry powder inhalers.

Publisher

Future Science Ltd

Subject

Pharmaceutical Science

Link

http://www.future-science.com/doi/pdf/10.4155/tde.11.100

Reference82 articles.

1. Nanoparticle therapeutics: an emerging treatment modality for cancer

2. Nanoparticle Processing in the Solid State Dramatically Increases the Cell Membrane Permeation of a Cholesterol-Lowering Drug, Probucol

3. Water Soluble Nanoparticles from PEG-Based Cationic Hyperbranched Polymer and RNA That Protect RNA from Enzymatic Degradation

4. A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System

5. Nanoparticle and targeted systems for cancer therapy

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern trends in the formulation of microparticles for lung delivery using porogens: methods, principles and examples;Pharmaceutical Development and Technology;2024-05-23

2. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

3. Pulmonary inhalation for disease treatment: Basic research and clinical translations;Materials Today Bio;2024-04

4. Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues;Journal of Drug Delivery Science and Technology;2024-02

5. Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude;Journal of Pharmaceutical Sciences;2023-10